Skip to content

Photodynamic Therapy in Treatment of Verrucae

PHOTODYNAMIC THERAPY USING METHYLENE BLUE AND INTENSE PULSED LIGHT VERSUS INTENSE PULSED LIGHT ALONE IN TREATMENT OF VERRUCA :A RANDOMIZED CONTROLLED STUDY

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04620785
Enrollment
80
Registered
2020-11-09
Start date
2020-01-01
Completion date
2022-05-01
Last updated
2021-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verruca Vulgaris

Brief summary

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.

Detailed description

This study will be conducted on: Eighty patients suffering of verruca (male and female) divided randomly into three groups: group A, B&C : Group A: 30 patients will undergo photodynamic therapy using intralesional 4%methylene blue solution and IPL. Group B: 30 patients will undergo IPL only. Group C (control group):20 patients will undergo intralesional saline.

Interventions

OTHERmethylene blue / IPL

therapeutic

OTHERIPL

therapeutic

OTHERsaline

placebo

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age:Above 16 years old. 2. Sex:Both males and female patients. 3. Clinically and dermoscopically documented verruca. 4. No verruca treatment in the last 2 weeks.

Exclusion criteria

1. History of photosensitivity disorder. 2. Pregnant and lactating females. 3. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus. 4. Anogenital warts. 5. Warts on head and neck.

Design outcomes

Primary

MeasureTime frameDescription
disappearance of verruca10 weeksclinical and dermoscopic cure

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026